Morgan Stanley Reports Strong 2025 Financials, Boosts Dividend, and Authorizes $20B Share Buyback
MS sits 84% above its 52-week low of $94.33.
Summary
Morgan Stanley reported strong financial results for 2025, with significant increases in net revenues, net income, and diluted EPS, driven by robust performance across all business segments and supported by strategic capital management actions.
Key Events · Earnings and Guidance · MS
-
Strong Financial Performance
Net revenues increased by 14% to $70.6 billion, net income applicable to Morgan Stanley rose by 26% to $16.9 billion, and diluted EPS grew by 28% to $10.21 for the year ended December 31, 2025.
-
Robust Profitability Metrics
The firm achieved a Return on Equity (ROE) of 16.6% and a Return on Tangible Common Equity (ROTCE) of 21.6%, alongside an improved expense efficiency ratio of 68%.
-
Significant Capital Management
The Board reauthorized a multi-year share repurchase program of up to $20 billion and increased the quarterly common stock dividend to $1.00 per share, effective July 16, 2025.
-
Favorable Regulatory Capital Position
The Stress Capital Buffer (SCB) was reduced from 5.1% to 4.3%, effective October 1, 2025, enhancing capital flexibility and remaining well above regulatory minimums.
Analysis · MS · Finance
Morgan Stanley's 2025 annual report showcases exceptional financial performance, with significant double-digit growth across net revenues, net income, and diluted EPS. The firm demonstrated robust profitability and improved operational efficiency, reinforcing its strong market position. Strategic capital management initiatives, including a notable dividend increase and a substantial share repurchase authorization, signal confidence in sustained performance and commitment to shareholder returns. The favorable reduction in the Stress Capital Buffer further enhances the firm's capital flexibility, positioning it well for future growth and stability.
At the time of this filing, MS was trading at $174.00 on NYSE in the Finance sector, with a market capitalization of approximately $277.1B. The 52-week trading range was $94.33 to $192.68. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.